Search

Big Data: What it is and why it matters for the Pharmaceutical Industry


When it comes to big data investments, maybe no other business has as much at risk and as much to gain as pharmaceuticals. Big data lays the groundwork for research and the development of new treatments and assists patients and caregivers in making better choices. By analysing large data sets, pharmaceutical companies can identify trends and patterns that might not be obvious with smaller data sets. This can lead to better decision-making about which drugs to develop and bring to market.

In this blog, we will discuss how big data is transforming the pharmaceutical industry, including leveraging advances in computing power, applying new approaches and technologies, and implementing solutions that combine traditional and emerging technologies.

Big Data and the Pharma 4.0 Revolution

Big data and the industry 4.0 revolution is changing how big pharma companies operate and their opportunities for collaboration and innovation. Big Data is the key driving force behind transforming the pharmaceutical industry. Pharma 4.0 refers to a digital revolution in the pharmaceutical industry that goes far beyond the use of just big data and analytics. 

Previously, manufacturing relied significantly on the human factor. However, industry 4.0 encompasses extensive connectivity and productivity improvements through automation and new ways to deliver personalised care on every journey. This brings together artificial intelligence (AI), robotics, machine learning, and data science in ways not previously possible.

But let's take it a step further. What kinds of data may businesses collect? It is impossible to provide an extensive list. Still, we must first establish a boundary that separates data related to internal corporate activities (such as manufacturing, distribution, and team member management) from data connected to customer management and communication. The latter may be divided into the following macro-categories:

  • Demographic data: Theseinclude age, gender, marital status, work position, and income level.

  • Psychographic data: Behaviours, views, values, interests, and lifestyles are all examples of psychographic data.

  • Geographic Data: It's critical data, particularly for those companies in the pharmaceutical industry that depend on their business proximity.

  • Behavioural Data: A type of information collected through cookies about users' online browsing habits.

  • Contextual Data: a broad area concerned with the context and environment in which we live, ranging from news to emotions to market swings.

  • First-Party Data: information gathered directly from users and customers by a business (or pharmacy), such as via CRM (Customer Relationship Management) systems.


Big Data relating to internal operations and big data confronting the outside world have various uses, services, and advantages. But both sides are crucial. Above all, knowing how to combine them is critical. This is where the so-called Pharma 4.0 revolution begins, which is the application of the logic and dynamics of Industry 4.0 and digitalisation to the pharmaceutical industry.

We'd like to examine several critical big data applications in the pharmaceutical industry and their benefits. We chose to outline them, covering topics that are purposefully extremely distinct from one another, merely to offer a sense of a very comprehensive perspective. 

Applications of Big Data in the Pharmaceutical Industry

Business leaders must build an effective big data adoption and implementation strategy to experience the advantages of big data in the pharmaceutical sector. This approach must account for the required infrastructure, interaction with corporate systems, the ever-increasing amount of collected data, and data security. Business executives must anticipate these difficulties and devise a thorough strategy to handle them.

Let us now go through the applications of Big Data in the pharmaceutical industry.

1. Reduces research and development costs. 

Many medication patents have expired or are about to expire. A poll found that releasing a new medicine might cost billions of dollars. Big data analytics may aid in the intelligent search of enormous data sets, including patents, scientific reports, and clinical trial data.  Big data analytics may aid in the intelligent search of enormous data sets, including patents, scientific reports, and clinical trial data. 

This understanding of patents, publications, and clinical trial data may aid researchers in discovering and developing innovative medications. A segment of the pharmaceutical sector has previously used big data analytics to improve the internet search of vast databases of old, new, and expired patents and relevant research materials.

2. Improve Clinical Trials 

Big data analytics has a wide range of applications in clinical trials. Various machine-learning algorithms may be used to match or recruit a patient. These algorithms decreased human intervention by 85%, saving costs and resources during major trials. Machine learning approaches such as association rules and predictions help identify patterns in patient acceptability, adherence, and other measures. 

Big data may aid in constructing flowcharts to match and attract more people to clinical trials, increasing the drug's success rate. A separate prediction model may assist in examining the new product's rivals based on various clinical and commercial circumstances. Big data models may also protect a company from potentially devastating scenarios caused by operational inefficiencies or other risky actions.

3. Develop Personalisation and Targeted Medications

Every human being has a distinct genetic structure. Ideally, medical treatments should be tailored to each individual. It is difficult to establish an accurate medical diagnosis when dealing with complex genetic data with existing biology and technology. To some extent, big data analytics may help the pharmaceutical business overcome this challenge. 

Big data may integrate genetic data, monitored medical data acquired by a device worn by the patient to measure physical changes during therapy, and electronic medical data records. Unstructured genetic data may be processed to discover trends using big data technology, allowing doctors to produce more effective and tailored medications for their patients.

4. Controlling Drug Reactions

With predictive modelling, real-world events are duplicated to assess the adverse effects of medications in clinical trials. Data mining on medical forums, as well as sentiment analysis, are used to acquire insight into adverse drug reactions (ADRs).

5. Improve Safety and Risk Management.

The internet, particularly social media, provides data signals that may serve as early warning signs concerning the safety of a newly released drug by the pharmaceutical industry. Side effect data are warning signs that are often unstructured and enormous in quantity. Big data analytics may be used in the pharmaceutical business to gather, analyse, and evaluate unstructured warning data.

6. Drive Marketing, Sales, and Supply Chain

Big data can be used to conduct consumer surveys and forecast the future sales of certain pharmaceuticals and their related demographics. 

These findings will help reach the appropriate consumer market in the long term. Using big data, data collection, and data analysis may increase supply chain visibility, allowing objectives to be aligned and expectations to be established correctly.

7. Improve Customer Care & Service

Pharmaceutical companies may obtain data via online discussions among stakeholders. The internet data sources can be used to decide on a new product launch and stay ahead of competitors. Big data analytics may assist them in analysing the impact of newly introduced products and forwarding the information to the safety department for appropriate action. Big data analytics may make it simpler for the pharmaceutical industry to acquire and handle consumer data, yielding valuable insights into predicting client demands.




Conclusion

Big data in the healthcare and medicine sectors refers to big and complicated data sets that are challenging to analyse with typical software or hardware. Big data analytics includes heterogeneous data integration, data quality management, analysis, modelling, interpretation, and validation. Big data analytics delivers complete knowledge discovery from the massive quantity of accessible data.

Whether using big data in precision medicine, lowering the number of medication failures, or lowering the cost of research and drug development, big data analytics has a promising future in the pharmaceutical industry. With data becoming the new oil, every pharma business that wants to give better and faster treatment to humanity must leverage this resource.

Please get in touch to understand how to fully utilise your data, manage multiple data sources, and transform your data with the Finworks scalable and secure data platform.